Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Kazia's Paxalisib Shows Positive Overall Survival Signal in Phase II Glioblastoma Study

prnasiaApril 07, 2020

Tag: Kazia , Paxalisib , Phase II Glioblastoma Study

PharmaSources Customer Service